2023-09-17T04:28:46+03:00[Europe/Moscow] en true <p>acute HF</p>, <p>acute decompensated HF</p>, <p>DOE, orthopnea, edema, GI issues</p>, <p>fatigue, cool extremities, pallor, confusion, oliguria </p>, <p>continue them unless renal issues or hyperkalemia </p>, <p>continue unless recent titration seems to be cause; if not currently on, don't start until stable</p>, <p>a</p>, <p>c</p>, <p>b</p>, <p>d</p>, <p>a</p>, <p>b</p>, <p>c</p>, <p>d</p>, <p>&gt;=2.2</p>, <p>&gt; 18</p>, <p>tachyphylaxis (tolerance), increased intracranial pressure</p>, <p>a</p>, <p>c</p>, <p>a</p>, <p>a</p>, <p>a,c</p>, <p>c</p>, <p>c</p>, <p>hepatic; renal </p>, <p>sodium nitroprusside; intense vasodilation</p>, <p>c</p>, <p>when red, blue, green, or dark brown</p>, <p>b</p>, <p>b</p>, <p>b</p>, <p>cardiogenic shock, bridge therapy to maintain perfusion</p>, <p>a</p>, <p>a</p>, <p>b,d</p>, <p>b,d </p>, <p>c</p>, <p>c</p>, <p>c</p>, <p>phentolamine mesylate </p>, <p>f</p>, <p>f</p>, <p>f</p>, <p>f</p>, <p>g</p>, <p>g</p>, <p>hemodynamics, BMP, EKG, CBC, vitals, GFR</p> flashcards
Therapeutic Management HF (Inpatient)

Therapeutic Management HF (Inpatient)

  • acute HF

    -refers to patients with sudden onset of HF symptoms that previously had normal function

  • acute decompensated HF

    -occurs in patients with existing HF

  • DOE, orthopnea, edema, GI issues

    What are the volume overload symptoms? (4)

  • fatigue, cool extremities, pallor, confusion, oliguria

    What are low cardiac output symptoms? (5)

  • continue them unless renal issues or hyperkalemia

    What do we do with ACEi/ARB/ARNI & AA when a patient has ADHF?

  • continue unless recent titration seems to be cause; if not currently on, don't start until stable

    What do we do with Beta Blockers when a patient has ADHF?

  • a

    Which patients are well perfused & don't have a fluid overload? ( warm & dry)

    a) subset 1

    b) subset 2

    c) subset 3

    d) subset 4

  • c

    Which patients have poor perfusion, but no fluid overload? (cold & dry)

    a) subset 1

    b) subset 2

    c) subset 3

    d) subset 4

  • b

    Which patients have good perfusion, but have fluid overload? (warm & wet)

    a) subset 1

    b) subset 2

    c) subset 3

    d) subset 4

  • d

    Which patients have poor perfusion and fluid overload. (wet & cold)

    a) subset 1

    b) subset 2

    c) subset 3

    d) subset 4

  • a

    Which can be treated at home?

    a) subset 1

    b) subset 2

    c) subset 3

    d) subset 4

  • b

    Which require ED visit + diuretics?

    a) subset 1

    b) subset 2

    c) subset 3

    d) subset 4

  • c

    Which are treated with vasodilators & inotropes?

    a) subset 1

    b) subset 2

    c) subset 3

    d) subset 4

  • d

    Which are treated with vasodilators, diuretics, and inotropes?

    a) subset 1

    b) subset 2

    c) subset 3

    d) subset 4

  • >=2.2

    Good perfusion =

  • > 18

    Pulmonary edema =

  • tachyphylaxis (tolerance), increased intracranial pressure

    What do we have to watch out for when administering vasodilators? (2)

  • a

    Which is good for pulmonary edema & IHD?

    a) nitroglycerine

    b) nesiritide

    c) sodium nitroprusside

  • c

    Which has the best effect on HR & CO?

    a) nitroglycerine

    b) nesiritide

    c) sodium nitroprusside

  • a

    Which has a half-life of minutes therefore must be taken IV?

    a) nitroglycerine

    b) nesiritide

    c) sodium nitroprusside

  • a

    Which do we have to use glass containers?

    a) nitroglycerine

    b) nesiritide

    c) sodium nitroprusside

  • a,c

    Which has to be protected from light?

    a) nitroglycerine

    b) nesiritide

    c) sodium nitroprusside

  • c

    Which uses a volumetric infusion pump?

    a) nitroglycerine

    b) nesiritide

    c) sodium nitroprusside

  • c

    Which can cause cyanide/thiocyanate toxicity?

    a) nitroglycerine

    b) nesiritide

    c) sodium nitroprusside

  • hepatic; renal

    Cyanide toxicity can occur in patients with _________ impairment while

    Thiocyanate toxicity can occur in patients with _______ impairment.

  • sodium nitroprusside; intense vasodilation

    Which medication in combination with PDE inhibitors should be avoided?

    What can this cause?

  • c

    Which has a light-brown tint?

    a) nitroglycerine

    b) nesiritide

    c) sodium nitroprusside

  • when red, blue, green, or dark brown

    When do we discard sodium nitroprusside?

  • b

    Which can increase CO, natriuresis, & diuresis?

    a) nitroglycerine

    b) nesiritide

    c) sodium nitroprusside

  • b

    Which is extremely expensive?

    a) nitroglycerine

    b) nesiritide

    c) sodium nitroprusside

  • b

    Which has the longest half-life?

    a) nitroglycerine

    b) nesiritide

    c) sodium nitroprusside

  • cardiogenic shock, bridge therapy to maintain perfusion

    When do we use inotropes? (2)

  • a

    Which really only affects Alpha-1?

    a) phenylephrine

    b) norepinephrine

    c) dopamine

    d) epinephrine

    f) dobutamine

  • a

    Which is mainly used for severe shock?

    a) phenylephrine

    b) norepinephrine

    c) dopamine

    d) epinephrine

    f) dobutamine

  • b,d

    Which are limited due to intense vasoconstriction & increased PR/afterload?

    a) phenylephrine

    b) norepinephrine

    c) dopamine

    d) epinephrine

    f) dobutamine

  • b,d

    Which can increase O2 demand, meaning we have to watch in patients with IHD?

    a) phenylephrine

    b) norepinephrine

    c) dopamine

    d) epinephrine

    f) dobutamine

  • c

    Which one can turn yellow, and should be discarded when that happens?

    a) phenylephrine

    b) norepinephrine

    c) dopamine

    d) epinephrine

    f) dobutamine

  • c

    Which has dose dependent actions?

    a) phenylephrine

    b) norepinephrine

    c) dopamine

    d) epinephrine

    f) dobutamine

  • c

    Which has a BBW for sloughing & necrosis (extravasation) ?

    a) phenylephrine

    b) norepinephrine

    c) dopamine

    d) epinephrine

    f) dobutamine

    g) milrinone

  • phentolamine mesylate

    -adrenergic blocking agent used when extravasation ( sloughing &

    necrosis) occurs

  • f

    Which has no IV bolus; rapid onset, and short half-life?

    a) phenylephrine

    b) norepinephrine

    c) dopamine

    d) epinephrine

    f) dobutamine

    g) milrinone

  • f

    Which CANNOT be stopped abruptly?

    a) phenylephrine

    b) norepinephrine

    c) dopamine

    d) epinephrine

    f) dobutamine

    g) milrinone

  • f

    Which has pink IV solutions?

    a) phenylephrine

    b) norepinephrine

    c) dopamine

    d) epinephrine

    f) dobutamine

    g) milrinone

  • f

    Which is CI in patients with sulfite/ corn allergy?

    a) phenylephrine

    b) norepinephrine

    c) dopamine

    d) epinephrine

    f) dobutamine

    g) milrinone

  • g

    Which is a PDE inhibitor?

    a) phenylephrine

    b) norepinephrine

    c) dopamine

    d) epinephrine

    f) dobutamine

    g) milrinone

  • g

    Which has the longest duration of action?

    a) phenylephrine

    b) norepinephrine

    c) dopamine

    d) epinephrine

    f) dobutamine

    g) milrinone

  • hemodynamics, BMP, EKG, CBC, vitals, GFR

    What do we monitor in Milrinone? (6)